Clinical Trial Imaging Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Research Scope & Content Outline

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Research Methodology
                    1.3. Research Scope & Assumption
                    1.4. Information Procurement
                         1.4.1. Purchased Database
                         1.4.2. GVR’s Internal Database
                         1.4.3. Secondary Sources & Third-Party Perspectives
                         1.4.4. Primary Research
                    1.5. Information Analysis
                         1.5.1. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Data Validation & Publishing
Chapter 2. Clinical Trial Imaging Services Market Intelligence
                    2.1. Category Definition
                    2.2. Category Intelligence
                         2.2.1. Market Size
                         2.2.2. Trends
                         2.2.3. Drivers
                         2.2.4. Challenges
                         2.2.5. Segmental Outlook
                         2.2.6. Regional Outlook
                    2.3. Technology
                         2.3.1. Emerging Technology
                         2.3.2. Best Practices in the Industry
                    2.4. Regulatory Landscape
                    2.5. Porter’s Five Forces Analysis
                         2.5.1. Bargaining power of suppliers
                         2.5.2. Bargaining power of buyers
                         2.5.3. Threat of substitutes
                         2.5.4. Threat of new entrants
                         2.5.5. Competitive rivalry
Chapter 3. Clinical Trial Imaging Services Market Supplier Intelligence
                    3.1. Identification of top 12 service providers
                         3.1.1. BioTelemetry, Inc. (part of Philips)
                         3.1.2. Clario
                         3.1.3. ICON plc
                         3.1.4. IXICO plc
                         3.1.5. Medical Metrics, Inc.
                         3.1.6. Medpace, Inc.
                         3.1.7. Navitas Life Sciences
                         3.1.8. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
                         3.1.9. ProScan Imaging, LLC
                         3.1.10. Radiant Sage LLC
                         3.1.11. Resonance Health Ltd. (Resonance Clinical)
                         3.1.12. WCG Clinical, Inc.
                    3.2. Clinical Trial Imaging Services Supply Chain Analysis
                    3.3. Clinical Trial Imaging Services Supplier Landscape
                    3.4. Clinical Trial Imaging Services Supplier Ranking Methodology
                         3.4.1. Supplier Operational Capabilities
                              3.4.1.1. Geographical Service Presence
                              3.4.1.2. Industries Served
                              3.4.1.3. Years in Service
                              3.4.1.4. Employee Strength
                              3.4.1.5. Revenue Generated
                              3.4.1.6. Certifications
                         3.4.2. Supplier Functional Capabilities
                              3.4.2.1. Modality
                                   3.4.2.1.1. X-Ray
                                   3.4.2.1.2. MRI
                                   3.4.2.1.3. Computed Tomography
                                   3.4.2.1.4. Others
                              3.4.2.2. End-User
                                   3.4.2.2.1. Pharmaceutical
                                   3.4.2.2.2. CRO
                                   3.4.2.2.3. Medical Device Manufacturer
                                   3.4.2.2.4. Others
                              3.4.2.3. Application
                                   3.4.2.3.1. NASH
                                   3.4.2.3.2. Kidney Disease
                                   3.4.2.3.3. Cardiovascular Disease
                                   3.4.2.3.4. Others
                              3.4.2.4. Products and Services
                                   3.4.2.4.1. Consultation
                                   3.4.2.4.2. Protocol Design
                                   3.4.2.4.3. Qualitative & Quantitative Analysis
                                   3.4.2.4.4. Others
                              3.4.2.5. Others
                    3.5. Clinical Trial Imaging Services Supplier Scoring Criteria
                    3.6. Clinical Trial Imaging Services Supplier Positional Matrix (SPM)
                         3.6.1. Rulers
                         3.6.2. Challengers
                         3.6.3. Loungers
                         3.6.4. Niches
                    3.7. Clinical Trial Imaging Services Supplier Market Concentration
                         3.7.1. Industry structure
                    3.8. Recommended Clinical Trial Imaging Services Service Providers
                         3.8.1. Supplier 1 with detailed profile
                         3.8.2. Supplier 2 with detailed profile
                         3.8.3. Supplier 3 with detailed profile
Chapter 4. Competitive Landscape
                    4.1. Recent Supplier Developments with Measured Impact
                         4.1.1. Joint Ventures
                         4.1.2. Mergers & Acquisitions
                         4.1.3. Collaborations or Partnerships
                         4.1.4. Other major developments
                    4.2. Supply-Demand Analysis
                         4.2.1. Supply Analysis
                         4.2.2. Demand Analysis
Chapter 5. Clinical Trial Imaging Services Pricing and Cost Intelligence
                    5.1. Cost Structure Overview
                         5.1.1. Staff
                         5.1.2. Software Tools
                         5.1.3. Logistics
                         5.1.4. Rent & Utilities
                         5.1.5. Certifications
                         5.1.6. Others
                    5.2. Pricing Intelligence
                         5.2.1. Factors Influencing the Rates for Clinical Trial Imaging Services
                         5.2.2. Raw Material Price Trend
                         5.2.3. Pricing Model Analysis
                              5.2.3.1. Cost plus or,
                              5.2.3.2. Volume based or,
                              5.2.3.3. Value based or,
                              5.2.3.4. Dynamic pricing model or,
                              5.2.3.5. Competitive pricing model or,
                              5.2.3.6. Others
                         5.2.4. Clinical Trial Imaging Service Rates - Service Providers Quotation
Chapter 6. Sourcing Intelligence
                    6.1. Engagement Model
                         6.1.1. Fully Outsourcing Model or,
                         6.1.2. Partial/Hybrid Outsourcing Model or,
                         6.1.3. In-house Product Development Model or,
                         6.1.4. Shared Service Model
                    6.2. Operating Model
                         6.2.1. Basic Provider or,
                         6.2.2. Approved Provider or,
                         6.2.3. Performance-based Model or,
                         6.2.4. Others
                    6.3. KPI/SLA Elements
                    6.4. Negotiation Strategies
                    6.5. LCC/BCC Sourcing Analysis
                         6.5.1. China
                         6.5.2. India
                         6.5.3. U.S.
                         6.5.4. Australia
                         6.5.5. U.K.
                         6.5.6. Insights on top 2 LCC/BCC Countries
                    6.6. Growth of Clinical Trials Market in China